Detalhe da pesquisa
1.
Evinacumab in Patients with Refractory Hypercholesterolemia.
N Engl J Med
; 383(24): 2307-2319, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196153
2.
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor ß for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Ophthalmology
; 127(2): 211-220, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791663
3.
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program.
Contemp Clin Trials
; 122: 106958, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208720
4.
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects.
Atherosclerosis
; 314: 33-40, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130482